Health Resources and Services Administration (HRSA); CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment, 57583 [E7-19879]

Download as PDF Federal Register / Vol. 72, No. 195 / Wednesday, October 10, 2007 / Notices 57583 Dated: October 2, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. E7–19887 Filed 10–9–07; 8:45 am] Dated: October 2, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. E7–19879 Filed 10–9–07; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Time and Date: 12 p.m.–2 p.m., October 24, 2007. Place: The conference call will originate at the National Center on Birth Defects and Developmental Disabilities (NCBDDD), in Atlanta, Georgia. Please see Supplementary Information for details on accessing the conference call. Status: Open to the public, limited only by the availability of telephone ports. Purpose: The Secretary is authorized by the Public Health Service Act, Section 399G, (42 U.S.C. Section 280f, as added by Pub. L. 105– 392) to establish a National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect to: (1) Foster coordination among all governmental agencies, academic bodies and community groups that conduct or support Fetal Alcohol Syndrome (FAS) and Fetal Alcohol Effect (FAE) research, programs and surveillance; and (2) to otherwise meet the general needs of populations actually or potentially impacted by FAS and FAE. Matters to be Discussed: The Task Force will convene via conference call to: (1) Discuss and vote on the Task Force report, ‘‘Reducing Alcohol-Exposed Pregnancies,’’ (2) provide an update on approved Task Force document, ‘‘Call to Action: Ensuring Research and Essential Services for Persons with FASDs and their Caregivers’’, and (3) discuss plans for disseminating final Task Force products. Agenda items are subject to change as priorities dictate. Supplementary Information: This conference call is scheduled to begin on October 24, 2007 at 12 p.m., Eastern Standard Time. To participate in the conference call, please dial 1 (866) 619–1481 and enter conference passcode 4832402. You will then be automatically connected to the call. Contact Person for More Information: Mary Kate Weber, M.P.H., Designated Federal Officer, NBDDD, CDC, 1600 Clifton Road, NE., Mailstop E–86, Atlanta, Georgia 30333. Telephone (404) 498–3926, Fax (404) 498– 3550. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the CDC and ATSDR. Health Resources and Services Administration (HRSA); CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention rwilkins on PROD1PC63 with NOTICES National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect VerDate Aug<31>2005 17:08 Oct 09, 2007 Jkt 214001 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), CDC announces the following meeting of the aforementioned committee: Times and Dates: 8 a.m.–5 p.m., November 15, 2007. 8 a.m.–12:15 p.m., November 16, 2007. Place: Doubletree Hotel Bethesda, 8120 Wisconsin Avenue, Bethesda, Maryland, Telephone (301) 652–2000, Fax (301) 664– 7317. Status: Open to the public, limited only by the space available. The meeting room will accommodate approximately 100 people. Purpose: This Committee is charged with advising the Director, CDC and the Administrator, HRSA, regarding activities related to prevention and control of HIV/ AIDS and other STDs, the support of health care services to persons living with HIV/ AIDS, and education of health professionals and the public about HIV/AIDS and other STDs. Matters to be Discussed: Agenda items include issues pertaining to (1) Implementation of the Ryan White HIV/AIDS Treatment Modernization Act of 2006; (2) HIV and STD Prevention and Treatment in Program Targeted to Native Americans, Alaska Natives, and Native Hawaiians; and the (3) Efforts to Integrate and Promote HIV/ STD Prevention and Management Strategies. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Margie Scott-Cseh, Committee Management Specialist, CDC, Strategic Business Unit, 1600 Clifton Road, NE., Mailstop E–07, Atlanta, Georgia 30333. Telephone (404) 639–8317, Fax (404) 639–8910, E-mail zkr7@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 National Institute for Occupational Safety and Health (NIOSH), Safety and Occupational Health Study Section In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting for the aforementioned committee: Times and Dates: 8 a.m.–5 p.m., October 25, 2007. 8 a.m.–5 p.m., October 26, 2007. Place: Embassy Suites Hotel, 1900 Diagonal Road, Alexandria, Virginia, 22314. Telephone (703) 684.5900, Fax (703) 684.1403. Purpose: The Safety and Occupational Health Study Section will review, discuss, and evaluate grant application(s) received in response to the Institute’s standard grants review and funding cycles pertaining to research issues in occupational safety and health, and allied areas. It is the intent of NIOSH to support broadbased research endeavors in keeping with the Institute’s program goals. This will lead to improved understanding and appreciation for the magnitude of the aggregate health burden associated with occupational injuries and illnesses, as well as to support more focused research projects, which will lead to improvements in the delivery of occupational safety and health services, and the prevention of work-related injury and illness. It is anticipated that research funded will promote these program goals. Matters to be Discussed: The meeting will convene to address matters related to the conduct of Study Section business and for the study section to consider safety and occupational health-related grant applications. These portions of the meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, Centers for Disease Control and Prevention, pursuant to Section 10(d) Pub. L. 92–463. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Price Connor, PhD, NIOSH Health Scientist, 1600 Clifton Road, NE., Mailstop E–20, Atlanta, Georgia 30333. Telephone (404) 498.2511, Fax (404) 498.2571. The Director, Management Analysis and Services Office, has been delegated the E:\FR\FM\10OCN1.SGM 10OCN1

Agencies

[Federal Register Volume 72, Number 195 (Wednesday, October 10, 2007)]
[Notices]
[Page 57583]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-19879]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Health Resources and Services Administration (HRSA); CDC/HRSA 
Advisory Committee on HIV and STD Prevention and Treatment

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), CDC announces the following meeting of 
the aforementioned committee:

    Times and Dates:
    8 a.m.-5 p.m., November 15, 2007.
    8 a.m.-12:15 p.m., November 16, 2007.
    Place: Doubletree Hotel Bethesda, 8120 Wisconsin Avenue, 
Bethesda, Maryland, Telephone (301) 652-2000, Fax (301) 664-7317.
    Status: Open to the public, limited only by the space available. 
The meeting room will accommodate approximately 100 people.
    Purpose: This Committee is charged with advising the Director, 
CDC and the Administrator, HRSA, regarding activities related to 
prevention and control of HIV/AIDS and other STDs, the support of 
health care services to persons living with HIV/AIDS, and education 
of health professionals and the public about HIV/AIDS and other 
STDs.
    Matters to be Discussed: Agenda items include issues pertaining 
to (1) Implementation of the Ryan White HIV/AIDS Treatment 
Modernization Act of 2006; (2) HIV and STD Prevention and Treatment 
in Program Targeted to Native Americans, Alaska Natives, and Native 
Hawaiians; and the (3) Efforts to Integrate and Promote HIV/STD 
Prevention and Management Strategies.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Margie Scott-Cseh, 
Committee Management Specialist, CDC, Strategic Business Unit, 1600 
Clifton Road, NE., Mailstop E-07, Atlanta, Georgia 30333. Telephone 
(404) 639-8317, Fax (404) 639-8910, E-mail zkr7@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: October 2, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention (CDC). Page
[FR Doc. E7-19879 Filed 10-9-07; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.